Plerixafor
Generic: Plerixafor
Labeler: Teva Pharmaceuticals, Inc.Drug Facts
Product Profile
Brand Name
Plerixafor
Generic Name
Plerixafor
Labeler
Teva Pharmaceuticals, Inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
PLERIXAFOR 24 mg/1.2mL
Identifiers & Regulatory
Product NDC
0480-4320
Product ID
0480-4320_389f8557-7dbc-40ac-8b68-e8e1a83f6325
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205197
Marketing Start
2023-07-28
Marketing End
2026-02-28
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04804320
Hyphenated Format
0480-4320
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
Plerixafor (source: ndc)
Generic Name
Plerixafor (source: ndc)
Application Number
ANDA205197 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 24 mg/1.2mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4320-01) / 1.2 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "389f8557-7dbc-40ac-8b68-e8e1a83f6325", "openfda": {"nui": ["N0000178326", "N0000178324"], "upc": ["0304804320013"], "unii": ["S915P5499N"], "rxcui": ["828700"], "spl_set_id": ["7027572d-cce6-42a7-9481-ec37c65fd460"], "pharm_class_pe": ["Increased Hematopoietic Stem Cell Mobilization [PE]"], "pharm_class_epc": ["Hematopoietic Stem Cell Mobilizer [EPC]"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4320-01) / 1.2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0480-4320-01", "marketing_end_date": "20260228", "marketing_start_date": "20230728"}], "brand_name": "Plerixafor", "product_id": "0480-4320_389f8557-7dbc-40ac-8b68-e8e1a83f6325", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Hematopoietic Stem Cell Mobilizer [EPC]", "Increased Hematopoietic Stem Cell Mobilization [PE]"], "product_ndc": "0480-4320", "generic_name": "Plerixafor", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Plerixafor", "active_ingredients": [{"name": "PLERIXAFOR", "strength": "24 mg/1.2mL"}], "application_number": "ANDA205197", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20230728"}